微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.62% | 113.01% | 14.41% | 58/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 2.29% | 209.46% | -8.4% | 33/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 2.5% | 207.14% | -3.47% | 72/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.59% | 33.51% | 110.57% | 76/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.23% | 41.38% | 66.22% | 79/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.74% | 100% | 131.71% | 79/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -2.33% | -206.07% | -220.28% | 109/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 1.94% | -57.73% | 122.99% | 90/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.87% | -65.2% | 135.14% | 89/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.37% | -86.19% | -83.18% | 96/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.2% | 322.9% | -52.07% | 95/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.59% | -33.19% | 83.6% | 70/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.5% | -44.44% | -6.72% | 73/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.68% | 0% | 371.53% | 48/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -0.99% | -133% | -114.37% | 116/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 6.87% | -10.89% | 52.67% | 73/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.5% | 16.88% | 67.91% | 73/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.68% | 31.37% | -10.4% | 61/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 2.99% | 148.88% | -61.2% | 115/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.71% | 12.88% | 100.26% | 76/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.85% | 3.77% | 88.73% | 93/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.04% | 12.71% | 133.33% | 73/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -6.12% | -156.93% | -189.6% | 122/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 6.83% | -24.7% | 84.1% | 64/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 3.71% | -35.92% | 104.97% | 82/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.81% | -36.71% | -83.16% | 44/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 10.75% | 66.93% | 18.52% | 75/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 9.07% | 20.93% | 56.65% | 35/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.79% | 26.7% | 102.45% | 37/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.86% | 20.17% | -55.59% | 20/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 6.44% | -31.71% | -14.13% | 84/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 7.5% | -4.82% | 64.11% | 33/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.57% | -6.54% | 92.02% | 32/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.38% | 15.53% | -74.76% | 26/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 9.43% | -1.87% | 19.67% | 67/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 7.88% | 13.38% | 61.15% | 28/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.89% | 6.07% | 137.38% | 34/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.06% | -3.29% | -78.56% | 25/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 9.61% | 18.06% | 38.27% | 54/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 6.95% | 18.8% | 50.76% | 21/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 4.61% | 16.12% | 116.43% | 29/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 2.13% | 5.97% | -73.83% | 17/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |